About Sialix
Sialix is developing products based on new biological discoveries of non-human sialic acids, their dietary role and inflammatory
consequences, and their potential impact on cancer, cardiovascular, and other inflammatory-mediated diseases. >> Read More
Scientific Foundation
Sialix’s scientific foundation was developed in the laboratory of Ajit Varki (University of California, San Diego), a world-leader in glycobiology. >> Read More
Sialix is developing immunotherapies against cancer-specific glycan structures present on the surface of tumor cells
Sialix is developing a proprietary dietary formulation to dampen the immune response induced by non human sialic acids in red meat
Sialix offers antibody kits to measure levels of Neu5Gc (N-glycolylneuraminic Acid) for academic and industry researchers